MedTrace Logo

High Energy Formula Feeding in Infants With Congenital Heart Disease

NCT01850784 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2013-05-10

No results posted yet for this study

Summary

High energy formula more positively affect growth in infants with congenital heart disease compared to standard formula

Conditions

Interventions

DIETARY_SUPPLEMENT

High energy formula

The infants with CHD will be fed with high energy formula (Similac; 1kcal/ml)

DIETARY_SUPPLEMENT

Standard formula

The infants with CHD will be fed with standard formula (0.6-0.7 kcal/ml)

Sponsors & Collaborators

  • Dr. Sami Ulus Children's Hospital

    lead OTHER

Principal Investigators

  • Dilek Dilli · Sami Ulus CH

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
8 Days
Max Age
6 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2014-02-28
Completion
2014-10-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01850784 on ClinicalTrials.gov